{"id":1335,"date":"2026-07-23T04:29:19","date_gmt":"2026-07-23T04:29:19","guid":{"rendered":"https:\/\/valutednews.com\/?p=1335"},"modified":"2026-07-23T04:29:19","modified_gmt":"2026-07-23T04:29:19","slug":"merck-summit-phrma-bayer-celldex-readout-newsletter","status":"publish","type":"post","link":"https:\/\/valutednews.com\/?p=1335","title":{"rendered":"Merck, Summit, PhRMA, Bayer, Celldex: Readout Newsletter"},"content":{"rendered":"
\"Merck,<\/div>

<\/p>\n

\n
\t\t\t\t\"\"
\n\t\t\t\t<\/source><\/source><\/picture>
Adobe<\/cite><\/figcaption><\/figure>\n
\n
\n
\"\"<\/div>\n
\"\"<\/div>\n<\/p><\/div>\n<\/p><\/div>\n
\n

Elaine\u2019s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter<\/a>, and co-hosts STAT\u2019s weekly biotech podcast, The Readout Loud<\/a>. You can reach Elaine on Signal at elaineywchen.70.<\/p>\n<\/div>\n

\n

Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of health care. Confidential tips can be sent on Signal at danielp.100.<\/p>\n<\/div>\n

\n

Want to stay on top of the science and politics driving biotech today?\u00a0Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/em><\/p>\n

Good morning. All my social media feeds have been filled with\u00a0Jimothy the raccoon<\/a>, and I hope your feeds\u00a0now will be too.<\/p>\n

The need-to-know this morning<\/h2>\n